Clinical Trials on Mycoses in United States
Total 2619 results
-
National Institute of Allergy and Infectious Diseases...Active, not recruiting
-
Mayo ClinicCompleted
-
University of PittsburghCompletedAcinetobacter InfectionsUnited States
-
University of PittsburghCelgene CorporationCompletedGram-negative Bacterial InfectionsUnited States
-
National Institute of Allergy and Infectious Diseases...Completed
-
Jared BrooksNorthwestern MedicineCompleted
-
University of Wisconsin, MadisonNational Institutes of Health (NIH); National Institute on Aging (NIA)CompletedClostridium DifficileUnited States
-
Daniel FreedbergCompleted
-
Virginia Commonwealth UniversityCubist Pharmaceuticals LLC; University HealthSystem ConsortiumCompleted
-
Rothman Institute OrthopaedicsUnknownStaphylococcus AureusUnited States
-
University of PittsburghCompletedAcinetobacter InfectionsUnited States
-
M.D. Anderson Cancer CenterCubist Pharmaceuticals LLCCompletedStaphylococcus AureusUnited States
-
Emory UniversityCompleted
-
MedImmune LLCCompletedStaphylococcus AureusUnited States
-
National Eye Institute (NEI)Completed
-
Centers for Disease Control and PreventionSouthcentral Foundation; Alaska Native Tribal Health ConsortiumCompletedPneumococcal InfectionsUnited States
-
Johns Hopkins UniversityVentria BioscienceUnknownClostridium DifficileUnited States
-
National Institute of Allergy and Infectious Diseases...CompletedMycosesUnited States
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Advanced Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | Recurrent Grade 3a Follicular Lymphoma | Recurrent Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma | Recurrent Mycosis Fungoides | Recurrent Primary Cutaneous... and other conditionsUnited States, Canada
-
National Institute of Allergy and Infectious Diseases...CompletedBacterial Infection | Pathogen Resistance | Multiple-drug ResistanceUnited States
-
SanofiCompletedClostridium InfectionsUnited States
-
PfizerCompletedAspergillosisUnited States, Australia, Canada, Greece, Belgium, Germany, Korea, Republic of, Poland, Russian Federation, Spain, Turkey, Thailand, Brazil, Czech Republic, France, India, Italy, Netherlands, Peru, Portugal, Singapore, Switzerland, ... and more
-
PfizerCompletedStaphylococcal InfectionsUnited States
-
Astellas Pharma IncCompletedCandidemia | Invasive Candidiasis | Esophageal Candidiasis | Oropharyngeal CandidiasisUnited States
-
ViametCompletedCandidiasis, VulvovaginalUnited States
-
PfizerCompletedHIV Infections | Meningitis, CryptococcalUnited States
-
Bausch Health Americas, Inc.CompletedOnychomycosisUnited States, Dominican Republic
-
George Washington UniversityWithdrawnPneumocystis Carinii PneumoniaUnited States
-
Glaxo WellcomeCompletedHIV Infections | Pneumonia, Pneumocystis CariniiUnited States
-
University of PittsburghMerck Sharp & Dohme LLCWithdrawnSurveillance Study - Incidence of Antibiotic Resistance in Serial Gram-negative Bloodstream IsolatesGram-negative Bacterial InfectionsUnited States
-
Hoffmann-La RocheCompletedGram-negative Bacterial InfectionsUnited States
-
Virginia Commonwealth UniversityAstellas Pharma IncCompletedStaphylococcus AureusUnited States
-
Michael E. DeBakey VA Medical CenterBaylor College of MedicineCompletedStaphylococcus AureusUnited States
-
Nabi BiopharmaceuticalsCompletedStaphylococcal Infections | Joint ProsthesisUnited States
-
Johns Hopkins UniversityNational Heart, Lung, and Blood Institute (NHLBI)RecruitingBiodistribution and Pharmacokinetics of Pretomanid in Tuberculosis Patients Using 18F-Pretomanid PETTuberculosisUnited States
-
VA Office of Research and DevelopmentTerminatedMicrobiota or Placebo After Antimicrobial Therapy for Recurrent C. Difficile at Home (MATCH) (MATCH)Clostridium Difficile InfectionUnited States
-
Emergent BioSolutionsNational Institutes of Health (NIH)CompletedAnthraxUnited States
-
PATHUniversity of Maryland, Baltimore; PharmaronCompleted
-
Global Alliance for TB Drug DevelopmentCompletedTuberculosisUnited States
-
QIAGEN Gaithersburg, IncCompleted
-
QIAGEN Gaithersburg, IncCompleted
-
National Institute of Allergy and Infectious Diseases...Completed
-
Vanderbilt UniversityCareFusion; Community Health NetworkCompleted
-
National Institute of Allergy and Infectious Diseases...Withdrawn
-
TD Vaccines A/SJohns Hopkins University; University of Vermont; SNBL Clinical Pharmacology Center... and other collaboratorsUnknown
-
Johns Hopkins Bloomberg School of Public HealthNational Institute of General Medical Sciences (NIGMS)RecruitingStaphylococcus Aureus InfectionUnited States
-
Jonathan GisserRecruitingClostridium DifficileUnited States
-
Methodist Health SystemCompleted